[ASND] QoQ Quarter Result on 31-Mar-2017 [#Q1]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
23-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -52.84%
YoY- -22.52%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Revenue 280 434 444 372 1,043 1,169 1,136 -60.58%
PBT -34,361 -34,117 -30,743 -25,153 -16,426 -18,311 -13,359 87.40%
Tax -186 -240 -37 -14 22 -57 -74 84.55%
NP -34,175 -33,877 -30,706 -25,139 -16,448 -18,254 -13,285 87.42%
Tax Rate - - - - - - - -
Total Cost 34,455 34,311 31,150 25,511 17,491 19,423 14,421 78.43%
Ratio Analysis
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
NP Margin -12,205.36 -7,805.76 -6,915.77 -6,757.80 -1,576.99 -1,561.51 -1,169.45 375.54%
Per Share
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
EPS -0.92 -1.04 -0.94 -0.78 -0.51 -0.72 -0.53 44.29%
EPS Diluted -0.88 -1.04 -0.94 -0.78 -0.51 -0.72 -0.53 40.08%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.